Clinical trial PM54-A-001-22
Phase I/Ib, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM54 Administered Intravenously to Patients with Selected Advanced Solid Tumors
| Organ | Multiple |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/1b |
| Academic trial | Non |
| Sponsor | PharmaMar |
| EudraCT Identifier | 2022-002031-65 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05841563 |
| Last update |